We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $141M
1-Year Est. Return 190.82%
This Fund
S&P 500
This Quarter Est. Return
+150.07%
1 Year Est. Return
+190.82%
3 Year Est. Return
+375.7%
5 Year Est. Return
+81.85%
10 Year Est. Return
+4,735.29%
AUM
$389M
AUM Growth
+$201M
Cap. Flow
-$275K
Cap. Flow %
-0.07%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
UTRS
Minerva Surgical, Inc. Common Stock
UTRS
+$275K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RYZB
1
DELISTED
RayzeBio, Inc. Common Stock
RYZB
$321M 82.47%
5,158,161
– –
CRSP icon
2
CRISPR Therapeutics
CRSP
$4.68B
$31.2M 8.03%
498,558
– –
RPTX
3
DELISTED
Repare Therapeutics
RPTX
$19.3M 4.97%
2,646,657
– –
GRTS
4
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$7.26M 1.87%
3,561,150
– –
PASG icon
5
Passage Bio
PASG
$14.7M
$5.01M 1.29%
247,988
– –
ADVM
6
DELISTED
Adverum Biotechnologies
ADVM
$3.82M 0.98%
506,823
– –
ALGS icon
7
Aligos Therapeutics
ALGS
$26.3M
$1.54M 0.4%
92,815
– –
UTRS
8
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
– –
-4,184
Closed -$275K

Similar funds

POIA
Pin Oak Investment Advisors Houston, Texas $141M AUM 20.83% 1-Year Est. Return
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
TM
TFJ Management Somerville, Massachusetts $141M AUM 9.28% 1-Year Est. Return
IA
IF Advisors San Antonio, Texas $141M AUM
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
RB
Renasant Bank Tupelo, Mississippi $141M AUM 16.9% 1-Year Est. Return
YEPX
Yorktown Energy Partners XI New York $142M AUM 130.51% 1-Year Est. Return
CFGW
Chancellor Financial Group WB Wilkes-Barre, Pennsylvania $141M AUM 23.22% 1-Year Est. Return

Versant Venture Management's Q4 2023 Portfolio in Review

As of Q4 2023, Versant Venture Management held 8 positions worth $389M, up 107% from $188M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Versant Venture Management's Q4 2023 filing shows 1 closed position. The largest sale was Minerva Surgical, Inc. Common Stock, an estimated $275K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Versant Venture Management fully exited Minerva Surgical, Inc. Common Stock in Q4 2023, selling an estimated $275K.
  • Versant Venture Management's ten largest holdings make up 100% of its $389M portfolio in Q4 2023.
  • Versant Venture Management opened 0 new positions and closed 1 in Q4 2023.
  • Versant Venture Management's portfolio value rose 107% quarter-over-quarter to $389M.

Based on Versant Venture Management's 13F filing for Q4 2023, filed 8 Feb 2024.